Drug Profile


Alternative Names: AT 1840; Lycobetaine acetate; Ungeremine acetate; Ungerimine acetate

Latest Information Update: 20 Jul 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nonindustrial sources
  • Class Alkaloids; Antineoplastics; Indolizines; Small molecules
  • Mechanism of Action DNA synthesis inhibitors; Mitosis inhibitors; RNA synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Cancer

Most Recent Events

  • 20 Jul 2006 No development reported - Preclinical for Cancer in Germany (unspecified route)
  • 05 Sep 2002 No development reported - Phase-I for Cancer in China (unspecified route)
  • 24 Jan 2001 Preclinical trials in Cancer in Germany (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top